Immuron Ltd has released a press release.
Immuron: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immuron
- Response to ASX Query
- Immuron Receives European Patent on Drug to Treat Diarrhea
- US DoD Travelan Clinical Update
- US DoD Naval Medical Research Center Clinical Update
- IMM124E Demonstrates Antiviral T-Cell Immunity
Later from Immuron
- Immuron Q3 Global Sales up 216% YoY
- Appointment of Mr Steven Lydeamore as Chef Executive Officer
- US DoD Uniformed Services University Clinical Update
- US DoD NMRC files IND application with FDA
- European Patent Notification on Drug Composition for CDI
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron